Latest news ...

Some of our recent news articles.

 
25
July
2019
25th July 2019
 

Taking Takeda global with new Irish pharma plant centre stage

Christophe Weber has overseen the $62 billion takeover of Shire and the opening of a new plant in Dublin

 
Read the full story »
 
 
05
December
2018
05th December 2018
 

Takeda wins shareholder approval for £46bn Shire acquisition

Vote paves way for Japan’s largest ever corporate takeover

 
Read the full story »
 
 
30
November
2018
30th November 2018
 

Irish giant Shire gets go-ahead to market new treatment

Takhzyro is a preventive treatment for the genetic condition hereditary angioedema

 
Read the full story »
 
 
10
September
2018
10th September 2018
 

New Shire plant to focus on treatment of rare diseases

Ground breaking treatments for people with rare genetic diseases will be manufactured in the massive Shire complex at Dunboyne, which will also serve as a European Quality control hub for the company.
 
Read the full story »
 
 
31
August
2018
31st August 2018
 

Shire Completes Sale of Oncology Franchise

Dublin, Ireland – August 31, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) announces today that it has completed the sale of its Oncology franchise to Servier S.A.S. for $2.4 billion. The franchise includes the global rights to ONCASPAR® and ex-US and ex-Taiwan rights to ONIVYDE®, as well as Oncology pipeline assets. David Lee, who was previously the head of Shire’s Global Genetic Diseases and Oncology franchises, will continue with Servier as CEO of its new US commercial subsidiary, Servier Pharmaceuticals.
 
Read the full story »
 
 
21
August
2018
21st August 2018
 

Shire Receives U.S. FDA Approval for New State-of-the-Art Plasma Manufacturing Facility Near Covington, Georgia

The FDA has approved the company’s first submission for its new plasma manufacturing facility near Covington, Georgia for the production of GAMMAGARD LIQUID® [Immune Globulin Infusion (Human)] 10% Solution, a replacement therapy for primary humoral immunodeficiency (PI).
 
Read the full story »
 
 
08
May
2018
08th May 2018
 

Japan’s Takeda agrees €52bn takeover of Irish-based Shire

Deal will propel Takeda into top ranks of global drugmakers
 
Read the full story »
 
 
25
April
2018
25th April 2018
 

Shire to recommend $64bn Takeda deal to shareholders

Acquisition would be largest ever outbound deal by Japanese company
 
Read the full story »
 
 
23
April
2018
23rd April 2018
 

After some Thursday drama, Shire weighs Takeda's cash-sweetened $61.5B offer

The third time wasn’t the charm for Takeda in its attempts to swallow Shire—but the fourth time might be.
 
Read the full story »
 
 
20
April
2018
20th April 2018
 

Allergan will not bid for Irish rare diseases specialist Shire

Reports had suggested pharma company would rival Takeda’s $60bn offer
 
Read the full story »
 
 
19
April
2018
19th April 2018
 

Shire faces bid battle from Allergan and Takeda

A bidding war for Shire is threatening to break out after Botox maker Allergan said it was considering a takeover offer for the rare diseases drug maker.

Shares in the London-listed firm jumped 9% after Reuters had reported Allergan's interest.
 
Read the full story »
 
 
16
April
2018
16th April 2018
 

Shire sells cancer drugs to Servier for $2.4 bn as Takeda circles

Divestment of the cancer business may be a deterrent for Takeda
 
Read the full story »
 
 
09
August
2017
09th August 2017
 

Shire may spin off ADHD drugs business

The pharma company upgrades guidance after strong first half
 
Read the full story »
 
 
08
May
2017
08th May 2017
 

Dublin-based Shire Pharmaceuticals sees earnings rise 14%

Firm planning to create 150 new jobs in State reports product sales up 110% to $3.4bn
 
Read the full story »
 
 
27
April
2017
27th April 2017
 

Pharmaceutical company Shire is to create 150 jobs at its new corporate offices in Ireland over the next few months.

The positions will be in the areas of procurement and finance and the new employees will provide support services to its global operations.
 
Read the full story »
 
 
12
December
2016
12th December 2016
 

Shire receives planning permission for Co Meath plant

Dublin-headquartered pharma giant is creating 400 jobs as part of the investment
 
Read the full story »
 
 
15
April
2016
15th April 2016
 

Shire to create 400 new jobs in Co Meath

400 new jobs are to be created in Co Meath over the next four years by Dublin based biotechnology company Shire.

The firm is to build a new $400m biologics manufacturing plant on a green field site at Piercetown.

Shire focuses on developing speciality treatments for rare diseases, neuroscience, as well as gastrointestinal and internal medicine.
 
Read the full story »
 
 
11
January
2016
11th January 2016
 

Drugmaker Shire wins Baxalta for $32 billion after six-month pursuit

Drugmaker Shire Plc clinched its six-month pursuit of Baxalta International Inc on Monday with an agreed $32 billion cash and stock offer, catapulting it to a leading position in treating rare diseases.
 
Read the full story »
 
 
31
December
2015
31st December 2015
 

Dublin-based Shire close to acquiring peer Baxalta

Dublin-based drug maker Shire has made a new acquisition offer for peer Baxalta International that is roughly in line with the latter’s valuation expectations, making a deal in the coming weeks likely, people familiar with the matter said.
 
Read the full story »
 
 
13
August
2015
13th August 2015
 

Shire seen having to raise $30bn Baxalta bid

Shire chief executive Flemming Ornskov is stepping up his campaign to get Baxalta to the negotiating table as he pushes the benefits a $30 billion takeover offer to the US biotech company’s shareholders.
 
Read the full story »
 
 
04
August
2015
04th August 2015
 

Drugmaker Shire bids $30bn for Baxter spin-off Baxalta

Drugmaker Shire said on Tuesday it was seeking to buy Baxalta, a company spun-off by Baxter International last month, for $30 billion (€27.35 billion) to forge the leading global specialist in rare diseases.
 
Read the full story »
 
 
08
June
2015
08th June 2015
 

Swiss biotech Actelion hits record high on potential Shire bid

Shire said to be considering a $18bn takeover of Swiss group to boost rare diseases business
 
Read the full story »
 
 
24
February
2015
24th February 2015
 

Shire buys Meritage Pharma for at least $70 million

(Reuters) - Dublin-based drugmaker Shire (SHP.L) said on Tuesday it had bought U.S. firm Meritage Pharma for at least $70 million, boosting its gastrointestinal drugs business.

Shire said it had obtained rights to buy privately-held Meritage in connection with its $4.2 billion acquisition of rare disease specialist Viropharma in 2014. The fee could rise if development and regulatory milestones are reached, it said.
 
Read the full story »
 
 
13
January
2015
13th January 2015
 

Shire in $5.2bn deal for US biotech NPS

Shire, the Irish-headquartered drugmaker, has made its biggest ever acquisition with a $5.2 billion deal for US biotechnology company NPS Pharmaceuticals, as the FTSE-100 group looks to build its pipeline of standalone speciality drugs.
 
Read the full story »
 
 
 
 
 
 
 
 
 

About Us

SURIMS is the new name for Actex Pharma Services which was a consultancy established in 2003, supporting companies in the identification, qualification and management of quality vendors and suppliers in ingredients and formulations.

The Pharmaceutical Services Directory supports the identification and on-boarding of quality suppliers and also incorporates software features that manage relationships between suppliers and their customers. These include the building and deployment of questionnaires and assessments, electronic signatures and sign-offs and project management between vendor/partner and customer.

Access to the features and software is available on a 'pay as you go' basis, or a customised version can be licensed for your company for its own supplier on-boarding and supplier management activities. Further information on our software services please contact Tel: +353 87 294 0436 or email info@pharmaservicesdirectory.com

 
 
 

Get in Touch

The Pharmaceutical Services Directory
info@pharmaservicesdirectory.com.

 
 

© 2019 Actex Pharma Services | All Rights Reserved.